These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12524149)

  • 1. Naloxone displacement at opioid receptor sites measured in vivo in the human brain.
    Melichar JK; Nutt DJ; Malizia AL
    Eur J Pharmacol; 2003 Jan; 459(2-3):217-9. PubMed ID: 12524149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of [11C]diprenorphine and [11C]carfentanil in vivo binding to opiate receptors in man using a dual detector system.
    Villemagne VL; Frost JJ; Dannals RF; Lever JR; Tanada S; Natarajan TK; Wilson AA; Ravert HT; Wagner HN
    Eur J Pharmacol; 1994 May; 257(1-2):195-7. PubMed ID: 7915990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model.
    Perry DC; Mullis KB; Oie S; Sadée W
    Brain Res; 1980 Oct; 199(1):49-61. PubMed ID: 6250676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography.
    Sadzot B; Price JC; Mayberg HS; Douglass KH; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Feldman MA
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):204-19. PubMed ID: 1847703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of three types of opioid binding sites in rat brain in vivo.
    Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W
    Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers.
    Jones AK; Luthra SK; Maziere B; Pike VW; Loc'h C; Crouzel C; Syrota A; Jones T
    J Neurosci Methods; 1988 Mar; 23(2):121-9. PubMed ID: 2833666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography.
    Frost JJ; Mayberg HS; Sadzot B; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Links JM
    J Cereb Blood Flow Metab; 1990 Jul; 10(4):484-92. PubMed ID: 2161414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and regional distributions of two distinct [3H]naloxone binding sites in the rat brain.
    Squires RF; Braestrup C
    J Neurochem; 1978 Jan; 30(1):231-6. PubMed ID: 202679
    [No Abstract]   [Full Text] [Related]  

  • 9. Opiate receptor binding in the pituitary gland.
    Simantov R; Snyder SH
    Brain Res; 1977 Mar; 124(1):178-84. PubMed ID: 191146
    [No Abstract]   [Full Text] [Related]  

  • 10. [3H]diprenorphine receptor binding in vivo and in vitro.
    Sadée W; Perry DC; Rosenbaum JS; Herz A
    Eur J Pharmacol; 1982 Jul; 81(3):431-40. PubMed ID: 6288412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An opiate binding site in the rat brain is highly selective for 4,5-epoxymorphinans.
    Grevel J; Sadée W
    Science; 1983 Sep; 221(4616):1198-201. PubMed ID: 6310750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro.
    Cunningham VJ; Hume SP; Price GR; Ahier RG; Cremer JE; Jones AK
    J Cereb Blood Flow Metab; 1991 Jan; 11(1):1-9. PubMed ID: 1845764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding.
    Ruiz-Gayo M; Baamonde A; Turcaud S; Fournie-Zaluski MC; Roques BP
    Brain Res; 1992 Feb; 571(2):306-12. PubMed ID: 1319268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
    Costa T; Wüster M; Gramsch C; Herz A
    Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
    Sadée W; Rosenbaum JS; Herz A
    J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.
    Hume SP; Lingford-Hughes AR; Nataf V; Hirani E; Ahmad R; Davies AN; Nutt DJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):661-7. PubMed ID: 17488881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
    Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
    Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
    Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
    J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of [11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols.
    Jones AK; Cunningham VJ; Ha-Kawa SK; Fujiwara T; Liyii Q; Luthra SK; Ashburner J; Osman S; Jones T
    J Neurosci Methods; 1994 Mar; 51(2):123-34. PubMed ID: 8051944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites.
    Itzhak Y; Hiller JM; Gioannini TL; Simon EJ
    Brain Res; 1984 Jan; 291(2):309-15. PubMed ID: 6320961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.